Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21191753 | 0.92 | CCR2 (0.35) | CCR2 | |
| SCHEMBL26653572 | 0.89 | CYP1A2 (0.34) | CCR2 | |
| SCHEMBL13930833 | 0.88 | CCR2 (0.32) | CCR2 | |
| SCHEMBL24317161 | 0.88 | CCR2 (0.32) | CCR2 | |
| SCHEMBL22024192 | 0.86 | CCR2 (0.39) | CCR2 | |
| SCHEMBL22023884 | 0.86 | CYP1A2 (0.34) | CCR2 | |
| SCHEMBL13930842 | 0.82 | KDM4E (0.35) | — | |
| SCHEMBL21180382 | 0.81 | CCR2 (0.35) | CCR2 | |
| SCHEMBL22022347 | 0.81 | CCR2 (0.35) | CCR2 | |
| SCHEMBL22023785 | 0.80 | PRCP (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210292320-A1 | FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS ANTIVIRAL AGENTS | ENANTA PHARMACEUTICALS, INC. | 2021-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210292320-A1 | FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS ANTIVIRAL AGENTS | HAVCR2, HDGF, HCCS | CCR2 586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.